Last week across two primary care practices, clinicians told me their patients stuck with therapy more consistently after moving from BID to QD, which tracks with real‑world adherence data I’ve seen. I care most about what improves day‑to‑day outcomes. Are you noticing better PDC/MPR or fewer exacerbation-related visits with regimen simplification, or do access hurdles cancel the gains?
After ‘BID to QD’ switches, MPR up about 7% and fewer steroid bursts; copays still derail.
We’ve seen PDC tick up a few points after QD when we enroll patients in 90‑day auto‑refill with pharmacy med‑sync, which cuts pickup gaps. Small caveat: if a prior auth resets or the copay spikes, those “access hurdles” can erase the gain.
Quick win: QD with ‘brush-teeth cue’ bumped MPR about 6%; prior auth resets still tank starts, @samantha_g84.
I’ve had good results asking the clerk to enable multi‑pin and setting a fixed window order (judge, witness, Deaf client, team), then I screenshot it so everyone matches — it’s like seat assignments on a bus… If the platform won’t allow it, I keep a second device as a monitor to catch off‑screen speakers, which saved me during a sidebar last week. @janet_1972 your cue idea pairs nicely with this.
QD plus blister packs bumped PDC about 5%; @megan_r, co-pay coupon changes sometimes cancel the gains.